Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

People with Fibromyalgia Syndrome often have skin symptoms, which can worsen their quality of life and increase depression.

A woman with lupus developed a rare skin condition, which improved with increased medication.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Lichen planus is linked to several autoimmune diseases.

Alopecia areata is linked to autoimmune antibodies.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

AMH is a promising biomarker for diagnosing PCOS.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

PRP treatment improves chronic tendinopathy, and imaging biomarkers can track tendon changes.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Psoriasis patients did not show more brain atrophy or small vessel disease than controls, but longer psoriasis duration was linked to more brain atrophy.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

TNF-alpha inhibitors can cause various immune-related skin issues.

Many lupus patients experience hair loss, which is linked to anxiety and other skin issues.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Ruxolitinib can cause a delayed skin reaction on the nose.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Educating primary care doctors and improving referrals to rheumatologists can reduce delays in treating lupus patients.

PRP injections help relieve hip pain in most cases.